GlassScriptPhysician profile
Jeffery Lee
NPI 1255667812
$1,751.66
in general payments reported to CMS, 2019-2025
18 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $39.74 · 2021: $161 · 2022: $279 · 2023: $483 · 2024: $354 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $304.30 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $284.27 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $229.45 | 2019-2023 | |
| Pfizer INC. | $207.13 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.48 | 2019-2025 | Relistor |
| Amgen INC. | $128.46 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $77.73 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $65.45 | 2021 | |
| Fisher & Paykel Healthcare INC | $58.99 | 2024 | Fisher & Paykel Healthcare |
| Scilex Pharmaceuticals INC. | $56.03 | 2021-2022 | |
| Zyla Life Sciences, INC. | $24.77 | 2019 | |
| Lundbeck LLC | $21.55 | 2023 | Vyepti |
| Averitas Pharma INC. | $18.46 | 2024 | Qutenza |
| Pacira Therapeutics, INC. | $17.66 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.33 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $15.12 | 2020 | |
| Relievant Medsystems, INC. | $13.68 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.